Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860340 · ClinicalTrials.gov registry record · NA
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
A NA study of Congestive Heart Failure, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT00860340 is a NA study of Congestive Heart Failure that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 18 participants, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00860340, a NA study of Congestive Heart Failure, has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single blind study.
Conditions Studied
Interventions
- DRUG Spironolactone
Study Locations (1)
Ohio
- Medical University of Ohio - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00860340
The ClinicalTrials.gov registry entry for NCT00860340 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 330-participant average among 51 other Congestive Heart Failure trials with a reported enrollment target (95% lower). The listed sponsor is University of Toledo Health Science Campus, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congestive Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Spironolactone is the first listed.
NCT00860340 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00860340 about?
NCT00860340 is a clinical study titled "Hemodynamic Effects of Spironolactone in Patients With Heart Failure". To determine if the beneficial effect of spironolactone in patients with congestive heart failure is in part due to its intrinsic inotropic action. Randomized, two group placebo controlled, single blind study.
What is the current status of trial NCT00860340?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2003-02. Estimated completion is 2006-10.
What conditions does trial NCT00860340 study?
This clinical trial studies the following conditions: Congestive Heart Failure.
What interventions are being tested in trial NCT00860340?
The interventions under investigation include: Spironolactone (DRUG).
Who is sponsoring clinical trial NCT00860340?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00860340 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congestive Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stress and Congestive Heart Failure
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Care Transitions App for Patients With Multiple Chronic Conditions
RECRUITING · NA
-
SyncAV Post-Market Trial
ACTIVE NOT RECRUITING · NA
-
Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)
ACTIVE NOT RECRUITING · NA
-
Congestive Heart Failure Pilot Study Utilizing Wireless Home Scale and Daily Symptom Monitoring
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.